Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amylin
Amylin
BYDUREON™ FDA Review Timeline Set With PDUFA Action Date Of October 22, 2010
Medical News Today
Sun, 05/9/10 - 12:49 pm
Bydureon
Amylin
Eli Lilly
Alkermes
type 2 diabetes
FDA to review Amylin, Lilly diabetes drug
Reuters
Fri, 05/7/10 - 08:35 am
FDA
Eli Lilly
Amylin
Byetta
diabetes
Make Money From 2020's Blockbuster Drugs
Motley Fool
Tue, 04/27/10 - 09:33 pm
Abbott Laboratories
Amgen
Bristol-Myers Squibb
Sanofi
Novartis
Pfizer
AstraZeneca
Amylin
Merck
Novo Nordisk
Amylin Pharmaceuticals' 1st-quarter loss narrows on lower sales force, research costs
Yahoo/AP
Mon, 04/19/10 - 11:30 am
Amylin
earnings
What’s Ahead for Biotech Earnings
Minyanville
Sat, 04/17/10 - 12:11 pm
biotech
earnings
Amylin
Gilead Sciences
Biogen Idec
Amgen
Genzyme
Biotech Earnings: Large-Cap Preview
TheStreet.com
Wed, 04/14/10 - 10:46 am
earnings
Amylin
Biogen Idec
Gilead Sciences
Vanda
Genzyme
Amgen
Alexion
Celgene
Allos
NVO's Victoza More Effective
Yahoo/Zacks.com
Wed, 03/31/10 - 10:05 am
Novo Nordisk
Victoza
diabetes
Amylin
GSK
Eli Lilly
FDA to Review VIVUS Drug
Yahoo/Zacks.com
Mon, 03/29/10 - 11:23 am
FDA
obesity
Vivus
Orexigen
Arena Pharmaceuticals
Qnexa
Amylin
FDA Says "No Way!" Market Says "Yeah, Baby!"(Byetta)
Motley Fool
Mon, 03/15/10 - 04:20 pm
FDA
Amylin
Alkermes
Byetta
diabetes
Eli Lilly
Amylin, Alkermes Gain as FDA Doesn’t Need More Byetta Data
Bloomberg
Mon, 03/15/10 - 11:49 am
Amylin
Alkermes
FDA
diabetes
Byetta
Industry News Bytes: Delcath, Amylin and Access Pharma
Seeking Alpha
Mon, 03/15/10 - 11:40 am
Delcath
Access Pharmaceuticals
Amylin
Eli Lilly
Alkermes
Eisai
Amylin shares fall ahead of diabetes drug decision
Yahoo/AP
Thu, 03/11/10 - 06:17 pm
diabetes
Amylin
Byetta
exanitide
FDA
10 Biotech Stocks On the Line
TheStreet.com
Thu, 03/11/10 - 08:57 am
Medivation
InterMune
Allos
Affymax
Amylin
Alkermes
Cell Therapeutics
Delcath
Dendreon
GenVec
MannKind
Somaxon
Vertex Pharmaceuticals
For Biotech in 2010, It's Déjà Vu All Over Again
Seeking Alpha
Mon, 03/8/10 - 10:23 am
Alkermes
Amylin
MannKind
Cell Therapeutics
Dendreon
Isis Pharmaceuticals
Amag Pharmaceuticals
XenoPort
Novelos Therapeutics
Adventrx
Delcath
Amylin Pharmaceuticals May Have a Great Shot
Barron's
Fri, 02/26/10 - 08:31 am
Amylin
exanitide
Amylin’s Other Drug to Watch
Minyanville
Wed, 02/24/10 - 10:10 am
Amylin
Takeda
obesity
Healthcare a Focus for Big Moves by Icahn
Yahoo/Indie Research
Fri, 02/19/10 - 10:52 am
Carl Icahn
Biogen Idec
Amylin
Genzyme
Forest Labs
Exelixis
Roche’s Diabetes Drug Meets Goals in Five Studies
Bloomberg
Thu, 02/11/10 - 08:37 am
Roche
diabetes
clinical trials
Lantus
Byetta
Januvia
taspoglutide
Eli Lilly
Merck
Amylin
Sanofi
2010 FDA Approvals Could Lead to Launch of Eight New Biotech Blockbusters
BNET Pharma
Tue, 02/9/10 - 11:14 am
FDA
Cadence Pharmaceuticals
Acorda Therapeutics
Auxilium
Gilead Sciences
Shire
Amylin
Cell Therapeutics
Dendreon
InterMune
Amgen
Human Genome
NicOx
Vivus
Arena Pharmaceuticals
Orexigen
Alkermes Retains Neutral Rec
Yahoo/Zacks.com
Tue, 02/9/10 - 09:35 am
Alkermes
Amylin
JNJ
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
next ›
last »